1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. GILEAD SCIENCES, INC.
Gilead Sciences, Inc. XNAS: GILD

Gilead Sciences, Inc. Live Stock Price Today, Share Analysis and Chart

Strong Performer, Getting Expensive
about

Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is...

Read More
114.76 0.53 (0.46%)
Near 52W High of $119.95
5.8M
XNAS Volume

XNAS 30 Jul, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Gilead Sciences, Inc. is on 08 Aug 2025 for the purpose of Gilead Sciences Inc Second Quarter Earnings Results for 2025 See details
Durability score
High Financial Strength
55.6 / 100
Valuation Score
Mid Valuation
49.2 / 100
Momentum Score
Technically Moderately Bullish
67.3 / 100
Strong Performer, Getting Expensive These stocks are strong in quality and technical aspects but with medium valuation. Due to expensive valuation it is suggested that opportunity to be observed before buying. View Similar Embed DVM
Analyst Price Target
118
1Yr Price target upside is 3%
26 analysts

13

S

4

W

1

O

2

T

SWOT Analysis

Gilead Sciences Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..